See more : The GO2 People Limited (GO2.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Formosa Optical Technology Co.,Ltd. (5312.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Formosa Optical Technology Co.,Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Centrais Elétricas de Santa Catarina S.A. (CLSC4.SA) Income Statement Analysis – Financial Results
- Bristol Water PLC (BWRA.L) Income Statement Analysis – Financial Results
- Shandong Delisi Food Co., Ltd. (002330.SZ) Income Statement Analysis – Financial Results
- SDI Group plc (SDIIF) Income Statement Analysis – Financial Results
- Advanced Biomedical Technologies, Inc. (ABMT) Income Statement Analysis – Financial Results
Formosa Optical Technology Co.,Ltd. (5312.TWO)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: https://www.formosa-optical.com.tw
About Formosa Optical Technology Co.,Ltd.
Formosa Optical Technology Co.,Ltd. provides eyecare products in Taiwan. The company offers optical glasses, sunglasses, contact transparent lenses, and color contact lenses. It also provides optometry equipment. The company was founded in 1976 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 3.86B | 3.30B | 2.91B | 3.06B | 3.22B |
| Cost of Revenue | 1.48B | 1.29B | 1.17B | 1.23B | 1.34B |
| Gross Profit | 2.38B | 2.01B | 1.75B | 1.83B | 1.87B |
| Gross Profit Ratio | 61.65% | 60.98% | 59.99% | 59.90% | 58.28% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 96.65M | 94.04M | 93.19M | 109.61M | 98.79M |
| Selling & Marketing | 1.96B | 1.73B | 1.59B | 1.60B | 1.61B |
| SG&A | 2.05B | 1.82B | 1.68B | 1.71B | 1.71B |
| Other Expenses | 0.00 | 58.08M | 118.61M | 70.74M | 0.00 |
| Operating Expenses | 2.05B | 1.82B | 1.68B | 1.71B | 1.71B |
| Cost & Expenses | 3.54B | 3.11B | 2.85B | 2.94B | 3.05B |
| Interest Income | 104.32M | 37.82M | 10.47M | 12.82M | 13.20M |
| Interest Expense | 36.60M | 28.99M | 21.38M | 20.83M | 19.76M |
| Depreciation & Amortization | 498.65M | 475.45M | 447.58M | 448.75M | 116.38M |
| EBITDA | 1.05B | 758.28M | 201.64M | 841.66M | 663.86M |
| EBITDA Ratio | 27.06% | 21.54% | 28.11% | 27.49% | 8.78% |
| Operating Income | 328.03M | 234.81M | 371.42M | 392.91M | 166.05M |
| Operating Income Ratio | 8.49% | 7.12% | 12.75% | 12.83% | 5.16% |
| Total Other Income/Expenses | 171.38M | 18.90M | 282.31M | 246.01M | 276.15M |
| Income Before Tax | 499.41M | 205.82M | 350.04M | 372.57M | 442.19M |
| Income Before Tax Ratio | 12.93% | 6.24% | 12.02% | 12.17% | 13.75% |
| Income Tax Expense | 81.51M | 35.64M | 64.39M | 67.35M | 65.28M |
| Net Income | 417.94M | 170.19M | 289.90M | 308.32M | 379.05M |
| Net Income Ratio | 10.82% | 5.16% | 9.95% | 10.07% | 11.79% |
| EPS | 6.96 | 2.83 | 4.83 | 5.13 | 6.31 |
| EPS Diluted | 6.94 | 2.83 | 4.81 | 5.12 | 6.29 |
| Weighted Avg Shares Out | 60.06M | 60.06M | 60.06M | 60.06M | 60.26M |
| Weighted Avg Shares Out (Dil) | 60.24M | 60.18M | 60.25M | 60.27M | 60.27M |
Source: https://incomestatements.info
Category: Stock Reports